David Visokey MD in Waterloo, Iowa

Home Iowa Waterloo

David Visokey MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 3421 W 9th St in Waterloo, Iowa.

They're a part of the: Covenant Medical Center Inc medical group which has around 209 members. You can call their office at 319-272-7050 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Des Moines University Of Osteopathic Medicine And Health Sciences and graduated in 1991 (around 34 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David M Visokey MD Office Phone and Directions

David Visokey MD
Covenant Medical Center Inc
3421 W 9th St
Waterloo, Iowa 50702
319-272-7050

Patient Ratings
Please rate your experience with David Visokey MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 319-272-7050

Enter a starting address:

Healthcare Info for David Visokey MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Des Moines University Of Osteopathic Medicine And Health Sciences
Graduation Year: 1991
The Primary Medical Specialty for David Visokey MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 34
PAC (PECOS ID)#: 3072521103
NPI #: 1912979261
NPI Created On: 02/02/2006
NPI Last Updated Listed as: 09/21/2016
Primary Taxonomy Code: 207RP1001X
License Number:
03104
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Medica Insurance Company
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Removal of fluid from chest cavity with imaging guidance
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788820295

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788820293

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 800270999

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Respiratory

Name of Drug #1: Always-On Tip Tracked Forceps, 1.8mm OD, Serrated Cup

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796208829

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801770433

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801773399

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801775933

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802113477

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802167821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802251281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Waterloo

1.
Pankaj Mehta

3421 W 9th St
Waterloo, IA
Covenant Medical Center Inc

2.
Pankaj Mehta

2710 Saint Francis Dr
Waterloo, IA
Covenant Medical Center Inc

3.
Colleen Overdorf

3421 W 9th St
Waterloo, IA
Covenant Medical Center Inc

4.
Hafiz Hashmi

1825 Logan Ave
Waterloo, IA
Allen Memorial Hospital Corporation

5.
Hafiz Hashmi

1825 Logan Ave
Waterloo, IA
Iowa Physicians Clinic Medical Foundation

6.
Hamad Azam

1825 Logan Ave
Waterloo, IA
Allen Memorial Hospital Corporation

Providers in Covenant Medical Center Inc

1.Baha Abbad

751 Main St
Arlington Ia 50606-9754
Covenant Medical Center Inc
Internal Medicine

2.Baha Abbad

515 College St
Cedar Falls Ia 50613-2500
Covenant Medical Center Inc
Internal Medicine

3.Baha Abbad

3421 W 9th St
Waterloo Ia 50702-5401
Covenant Medical Center Inc
Internal Medicine

4.Victor Abrich

2710 Saint Francis Dr
Waterloo Ia 50702-5620
Covenant Medical Center Inc
Cardiac Electrophysiology

5.Samer Abu Alula

751 Main St
Arlington Ia 50606-9754
Covenant Medical Center Inc
Internal Medicine

6.Samer Abu Alula

3421 W 9th St
Waterloo Ia 50702-5401
Covenant Medical Center Inc
Internal Medicine

View all 209 members of Covenant Medical Center Inc medical group